Sylvie Morgeaux

Lyon, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Establishment of hepatitis A virus coating reagent batch 2 for in vitro potency assay of hepatitis A vaccines by ELISA.

Establishment of hepatitis A virus coating reagent batch 2 for in vitro potency assay of hepatitis A vaccines by ELISA.

Journal: Pharmeuropa bio & scientific notes
Published: December 03, 2024

Establishment of Ph. Eur. Bordetella pertussis mouse antiserum Biological Reference Preparation batches 2, 3 and 4.

Establishment of Ph. Eur. Bordetella pertussis mouse antiserum Biological Reference Preparation batches 2, 3 and 4.

Journal: Pharmeuropa bio & scientific notes
Published: August 14, 2020

Production and characterisation of a candidate hyper-immune serum for the replacement of the Bordetella pertussis mouse antiserum Biological Reference Preparation.

Production and characterisation of a candidate hyper-immune serum for the replacement of the Bordetella pertussis mouse antiserum Biological Reference Preparation.

Journal: Pharmeuropa bio & scientific notes
Published: August 14, 2020

Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA.

Establishment of detection antibodies BRRs batch 5 for in vitro potency assay of hepatitis A vaccines by ELISA.

Journal: Pharmeuropa bio & scientific notes
Published: January 17, 2019

Establishment of detection antibodies BRRs batch 4 for in vitro potency assay of hepatitis A vaccines by ELISA.

Establishment of detection antibodies BRRs batch 4 for in vitro potency assay of hepatitis A vaccines by ELISA.

Journal: Pharmeuropa bio & scientific notes
Published: January 13, 2018

Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - Results of an international collaborative study.

Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA - Results of an international collaborative study.

Journal: Vaccine
Published: October 05, 2016

Development and validation of a quantitative competitive ELISA for potency testing of equine anti rabies sera with other potential use.

Development and validation of a quantitative competitive ELISA for potency testing of equine anti rabies sera with other potential use.

Journal: Vaccine
Published: February 19, 2016

Establishment of hepatitis A vaccine (inactivated, non-adsorbed) BRP batches 2 and 3.

Establishment of hepatitis A vaccine (inactivated, non-adsorbed) BRP batches 2 and 3.

Journal: Pharmeuropa bio & scientific notes
Published: February 03, 2016

Establishment of hepatitis A detection antibodies set BRR batch 3 for antigen content determination by ELISA.

Establishment of hepatitis A detection antibodies set BRR batch 3 for antigen content determination by ELISA.

Journal: Pharmeuropa bio & scientific notes
Published: February 03, 2016

Validation of a new ELISA method for in vitro potency testing of hepatitis A vaccines.

Validation of a new ELISA method for in vitro potency testing of hepatitis A vaccines.

Journal: Pharmeuropa bio & scientific notes
Published: January 23, 2014

A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release.

A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release.

Journal: Vaccine
Published: May 31, 2013
Showing 1-11 of 11

Last Updated: 09/26/2026